arrow
D

Dario Bruzzese

university of naples federico ii
H指数:43
被引数:6,015

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Absolute and lung volume-normalized deep learning-derived pulmonary vascular measures in idiopathic pulmonary fibrosis: distinct clinical associations and the role of lung volume in prognosis

特发性肺纤维化中绝对和肺容积校正的深度学习衍生肺血管测量指标:不同的临床关联及肺容积在预后中的作用

2026-09-290
OAAI
Educational professional activities for enhancing heart failure guidelines implementation: data from the Optimization of Therapy in the Italian Management of Heart Failure (OpTIMa-HF) Registry

针对心力衰竭指南实施的教育专业活动:意大利心力衰竭管理中的优化治疗(OpTIMa-HF)登记研究数据

2026-08-040
OA
CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients

CCL2:结直肠癌患者中的一种促炎驱动因子和候选诊断生物标志物

2026-07-230
OAAI
BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG

BLOSSOM饮食习惯与接受BCG治疗的高风险非肌层浸润性膀胱癌患者1年内腔内复发

2026-02-270
OAAI
Can Early Nutrition Be Responsible for Future Gut Microbiota Changes and Different Health Outcomes?

早期营养是否会对未来肠道微生物组的改变和不同的健康结局负责?

2025-11-270
OAAI
Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

PREVES-HOR问卷的开发与验证:一种用于接受雄激素剥夺治疗的前列腺癌患者激素疗法相关生活质量的自评量表

2025-09-010
PRE
Trastuzumab plus lapatinib or chemotherapy in patients with HER2-overexpressed advanced breast cancer: a randomized, phase II trial (GIM12-TYPHER)

曲妥珠单抗联合拉帕替尼或化疗在HER2过表达的晚期乳腺癌患者中的应用:一项随机、II期试验(GIM12-TYPHER)

2025-07-010
OAAI
A systematic review of the predictive factors for the recurrence of acute pancreatitis

急性胰腺炎复发的预测因素系统综述

2025-04-120
OA
Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction A Randomized, Double-Blind, Placebo-Controlled Trial

生长激素替代疗法在射血分数降低的心力衰竭中的应用:一项随机、双盲、安慰剂对照试验

2025-04-011
OAAI
Machine learning for the rElapse risk eValuation in acute biliary pancreatitis: The deep learning MINERVA study protocol
2025-03-030
OAAI
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study
2025-03-010
OAAI
Neutrophil-to-lymphocyte ratio: link to congestion, inflammation, and mortality in outpatients with heart failure

中性粒细胞与淋巴细胞比率: 与心力衰竭门诊患者的充血,炎症和死亡率有关

2025-03-010
OA
Real-World Efficacy and Safety of Inclisiran A Single-Country, Multicenter, Observational Study (CHOLINET Registry)

瑞鲁(Inclisiran)的真实世界疗效与安全性:一项单国家、多中心、观察性研究(CHOLINET登记研究)

2025-02-013
PRE